SRC and non-small cell lung carcinoma: A range of constitutively-active oncogenic EGFR mutants found in non-small cell lung cancer (NSCLC) traffic into the ERC, allowing them to engage in a preferential interaction with Src, a crucial partner for EGFR-mediated oncogenesis [75].